ShowcasesPricing
  1. US-listed companies
  2. OPGEN INC

OPGEN INCOPGN

Market cap
$4.61M
P/E ratio
Back to summarized table
Income statementBalance sheetCash flow
Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2022
Product sales------2
Laboratory services------172,633
Collaboration revenue------540,798
Total revenue3433343
Product sales---1911,5653-
Laboratory services---625,516720,156488,211-
Cost of products sold------3
Cost of services------104,405
Research and development, net69765108
General and administrative6777699
Sales and marketing4632134
Impairment of right-of-use asset----520,759101,838-
Impairment of intangible assets-----750,5965
Goodwill impairment charge------7
Total operating expenses-231816162737
Operating loss-15,059,163-19,009,337-15,265,791-13,180,242-12,271,245-22,718,479-34,567,121
Gain on extinguishment of debt-----884,970-
Interest and other income, net--5,967-87,2555,3849,859105,62746,935
Interest expense2143,347233,505191,195187,54933
Foreign currency transaction gains--8,10223,179-10,4312,410-1,468,855379,622
Change in fair value of derivative financial instruments--144,0648,38667517,680113,741
Total other expense-2,422,005-157,416-153,517-187,856-175,213-3,359,962-2,716,112
Loss before income taxes-17,481,168-19,166,753-15,419,308-13,368,098-12,446,458-26,078,441-37,283,233
Provision for income taxes-129,095----132,403-
Net loss-17,352,073-19,166,753-15,419,308-13,368,098-12,446,458-26,210,844-37,283,233
Deemed dividend on beneficial conversion feature-332,550-----
Net loss available to common stockholders-17,595,835-19,499,303-15,419,308----37,283,233
Basic and diluted net loss per share attributable to common stockholders (in Dollars per share)-------15.27
Net loss-17,352,073-19,166,753-15,419,308-13,368,098-12,446,458-26,210,844-37,283,233
Other comprehensive loss - foreign currency translation-1,0597,235-32,07612,807-4,2223-1,381,466
Comprehensive loss-17,353,132-19,159,518-15,451,384-13,355,291-12,450,680-23,646,347-38,664,699